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Summary
Background: The activity of the Bicoid (Bcd) transcrip-
tion factor is a useful example of how quantitative infor-
mation contained in a smooth morphogen gradient is
transformed into discrete and precise patterns of target
gene expression. There are two distinct and important
aspects to this process: the “sharpening” of the pos-
terior borders of the expression domains and the
“precision” of where the target genes are expressed
along the length of the embryo as the syncytial embryo
begins to cellularize. Although the sharpening phenom-
enon was observed over a decade ago, it is still poorly
understood.
Results: Here, we show that a Bcd reporter gene con-
taining binding sites only for Bcd is expressed, like nat-
ural targets of Bcd, in a precise domain with a sharp
boundary. Analysis of embryos expressing deleted
forms of Bcd indicates that the sharpness of the Bcd
target gene hunchback’s expression involves the gluta-
mine-rich and C-terminal activation domains of Bcd.
Furthermore, several artificial Gal4-derived transcrip-
tion factors expressed as gradients in the embryo share
Bcd’s ability to drive precise target gene expression
with sharp boundaries.
Conclusion: Thus, contrary to recent reports proposing
that the Bcd gradient is not sufficient to establish pre-
cise positional information, we show that Bcd drives
precise and sharp expression of its target genes
through a process that depends exclusively on its abil-
ity to activate transcription.
Introduction
The involvement of gradients in pattern formation was
first postulated by Morgan more than a century ago [1]
and their importance revisited by Wolpert in the 1970s,
when he proposed the French flag model for the func-
tioning of a morphogen gradient [2]. According to this
model, cells acquire distinct fates during development
by responding to different thresholds of the morphogen
in different ways [1, 2]. The first molecular evidence for
the existence of such morphogen gradients was pro-
vided in 1988 by Driever and Nüsslein-Volhard, when
they reported that a gradient of the transcription factor
Bicoid (Bcd) was involved in development of the ante-
roposterior (A-P) axis of the Drosophila embryo [3, 4].*Correspondence: nathalie.dostatni@curie.frThe bcd mRNA is produced during oogenesis and an-
chored at the anterior pole of the embryo, where it is
translated soon after the egg is laid. Unlike its mRNA,
the Bcd protein can diffuse along the A-P axis, giving
rise to a concentration gradient with its highest point at
the anterior pole [3]. Bcd is a homeodomain-containing
transcription factor that becomes active in the embryo
when zygotic transcription begins about 1.5 hr postfer-
tilization and egg laying [4–6]. High levels of Bcd pro-
mote the expression of genes such as orthodenticle
(otd) in the most anterior part of the embryo, whereas
lower levels allow expression of hunchback (hb) in the
entire anterior half of the embryo (Figure 1). Molecular
approaches have shown that the Bcd gradient behaves
as predicted by Wolpert’s French flag model. (1) Func-
tional binding sites for Bcd, which differ in their number
and affinity for the protein, are found in the regulatory
regions of target genes [7, 8]. (2) Reporter genes placed
under the control of low-affinity Bcd binding sites are
expressed more anteriorly in the embryo than reporters
placed under the control of high-affinity binding sites
[6, 7]. (3) Increasing the amount of Bcd in the embryo
by inserting additional copies of the bcd gene in trans-
genic females shifts the entire fate map of the embryo
toward the posterior pole [4], as indicated by a shift in
the expression of all the Bcd target genes tested [4, 6,
9, 10]. This Bcd-driven positional information is subse-
quently ensured along the A-P axis through the in-
terplay of Bcd and some of its direct target gene prod-
ucts such as the Hb, Krüppel (Kr), and Giant proteins,
which are themselves transcriptional activators and re-
pressors [11, 12]. So, the establishment and interpreta-
tion of positional information by Bcd are closely related
processes in the early embryo [13].
Recent studies, however, have questioned whether
Bcd alone is sufficient to provide precise positional in-
formation along the A-P axis [14, 15]. Quantitative im-
munofluorescence microscopy indicated great variabil-
ity in the position of the Bcd gradient along the A-P
axis: a given level of Bcd was found at positions that
varied by up to 30% of the egg length (EL) among a
sample of embryos. By contrast, the same type of de-
tection indicated that the position of the posterior bor-
der of Hb expression varied by only 4% of the EL. Be-
cause the precision of the hb target gene’s expression
was apparently far superior to the precision of morpho-
gen expression, these observations suggested that the
French flag model does not hold true for Bcd. Houch-
mandzadeh et al. proposed that another system must
exist to filter out the “noise” associated with the vari-
ability of the Bcd gradient and establish precise ex-
pression of Bcd’s targets. They found that the precise
positioning of hb expression depends on another gene,
staufen (stau), the product of which is involved in intra-
cellular RNA localization and, in particular, in the an-
choring of both bcd and oskar mRNAs at the poles of
the embryo [16, 17]. Because most of Bcd’s targets are
also targets for the Hb protein [18], it was proposed
that the precise positioning of hb expression by Stau
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1889Figure 1. The Bcd Morphogen in the Blastoderm Embryo and the French Flag Model
The Bcd gradient with its highest point at the anterior pole revealed by antibody staining (A) and expression of the two Bcd target genes, otd
(B) and hb (C), revealed by in situ hybridization performed with antisense probes. The position of the posterior border of expression is
indicated with arrowheads. The concentration gradient of the Bcd protein (arbitrary units) is indicated on the graph by a dotted line as a
function of the percentage of EL. According to the French flag model, the two target genes, otd (blue) and hb (white), are expressed at
concentrations of Bcd above a specific threshold indicated by the arrowheads. Note that the posterior expression of hb is not dependent on
Bcd. Anterior is at the left.might contribute to establish precise expression of Bcd
targets [14, 15].
To determine how the information contained in the
smooth gradient of Bcd is transformed into precisely
sized domains of expression with sharp boundaries, we
analyzed the sharpness of the posterior border and the
precision of expression of three direct target genes of
Bcd: hb, otd [8], and Bcd3-lacZ, a synthetic Bcd repor-
ter gene [10]. We find that the presence of Bcd binding
sites in a target promoter is sufficient for its sharp ex-
pression. We identify two activation domains of Bcd
important for the sharpening of hb and show that artifi-
cial Gal4-derived transcription factors expressed, like
Bcd, as maternal gradients in the early Drosophila
embryo also drive sharp expression of Gal4 reporter
genes. Interestingly, otd, the Bcd-dependent and the
Gal4-dependent reporters are expressed as precisely
as hb in wild-type embryos, and this precision is re-
duced in a stauHL mutant background. The effect of
Stau is observed on all target genes tested and thus
occurs upstream or at the level of the transactivation
process. Bcd is thus sufficient to determine sharp and
precise expression of its target genes through a pro-
cess that depends only on its ability to activate tran-
scription. We finally show that the bcd mRNA distribu-
tion pattern is much more variable in embryos from
stauHL females than in wild-type embryos and propose
that the effect of the stauHL mutant background on theprecision of Bcd activity occurs through the anchoring
of the bcd mRNA at the anterior pole of the embryo.
Results
Bcd Is Sufficient for the Sharpening of the Posterior
Border of Its Target Genes
To gain insights into Bcd’s morphogenic activity, we an-
alyzed the expression of its direct natural targets hb
and otd, and a synthetic Bcd reporter gene, Bcd3-lacZ
[10]. This reporter places lacZ under the control of a
simple promoter containing three strong artificial Bcd
binding sites and no known binding site for other tran-
scription factors. It allows the intrinsic ability of Bcd to
activate transcription to be detected in vivo [19, 20]. In
situ hybridization indicated that the expression pat-
terns of these three target genes vary substantially
during the first half of cellularization (Figure 2). Using
Nomarski microscopy, we classified embryos into two
stages based on the position of their basal membrane:
early embryos were blastoderm embryos that had not
started cellularization yet, and midstage embryos were
embryos that had started but not reached 50% of the
process. In early embryos, the three target genes, hb,
otd, and Bcd3-lacZ, were expressed in anterior do-
mains of different sizes that had a diffuse posterior bor-
der, their expression diminishing over several nuclei
(Figures 2A–2C, brackets). During the first half of cellu-
Current Biology
1890Figure 2. The Shape of the Posterior Border of Bcd Targets Is Modified during Blastoderm Development
In situ hybridizations were performed on wild-type early-stage (A–C) and midstage (D–F) embryos with hb (A and D), otd (B and E), and lacZ
(C and F) antisense probes. Embryos carried the Bcd3-lacZ transgene (C and F). Diffuse borders of expression in early embryos are indicated
by brackets. Sharp borders of expression in mid embryos are shown with arrowheads. (D–F) Sharpening was measured (see Figure S1 and
Supplemental Experimental Procedures) on 30 to 50 (n) midstage embryos, and average measurements are indicated at the bottom. Anterior
is at the left.larization, however, the posterior boundary of hb and
otd extended to not more than one or two nuclei and
appeared much sharper than in early embryos (Figures
2D and 2E, arrowhead). We quantified the sharpness of
the expression domains (i.e., the distance between the
most posterior position of highest expression and the
most anterior position of lowest expression) as a pro-
portion of EL along the A-P axis (see Figure S1 and the
Supplemental Experimental Procedures available with
this article online). We found that this distance was
5.8% EL for hb and 4.6% EL for otd. We observed a
similar sharpness of expression (5.4% EL) for Bcd3-
lacZ (Figure 2F, arrowhead and Figure S1), indicating
that sharpening clearly occurs when the promoter lacks
binding sites for specific transcription factors other
than Bcd. We conclude that Bcd binding sites are suffi-
cient in a promoter to induce the sharpness of its ex-
pression domain posterior border.
The Sharpness of the hb Posterior Border
Is Reduced in bcd Mutants
The existence of transgenic flies expressing deleted
versions of the bcd gene [21] offered the opportunity to
identify domains of Bcd involved in the sharpening of
hb expression. We performed in situ hybridization on
midstage embryos expressing these truncated versions
of Bcd and lacking wild-type Bcd. In most cases, no
change in the shape of hb posterior border was ob-
served (not shown). Interestingly, however, when either
the C (Bcd-DC) or both Q and C (Bcd-DQC) activation
domains of Bcd (Figure 3) were deleted [20], the hb bor-
der was much more diffuse than normal (see brackets
in Figures 3B and 3C). Quantitative measurements indi-
cated that the sharpness of the hb posterior border was
13.6% EL in Bcd-DC embryos and 19.6% EL in Bcd-
DQC embryos (compare Figures 3B and 3C; Figure S2).
Because the reduction hb posterior border sharpen-
ing in the Bcd-DQC and Bcd-DC lines might be due to
t
m
F
p
f
p
s
t
t
i
f
9
t
S
n
t
t
w
a
t
s
G
B
T
o
w
l
s
p
m
t
t
2
t
a
m
the intrinsic anterior shift of the whole embryo’s fate
ap in these backgrounds (compare Figure 2D with
igures 3B and 3C), we analyzed the shape of the hb
osterior border in embryos from females homozygous
or bcdE3. This hypomorphic allele of bcd carries a
oint mutation in the homeodomain and induces also a
ignificant shift of the whole fate map of the embryo
oward the anterior (Figure 3D). It encodes a Bcd mu-
ant protein that is affected in DNA binding rather than
n transcriptional activation [6]. In embryos from bcdE3
emales, the posterior border of hb sharpened over only
.3% EL despite its even more anterior position than in
he Bcd-DQC and Bcd-DC embryos (Figures 3D and
2). Together, these observations indicate that there is
o correlation between the strength of the reduction in
he sharpening of hb posterior border and the magni-
ude of the anterior shifts of fate map indicative of a
eaker Bcd activity. These reductions of sharpening
re therefore rather due to specific defects in the activi-
ies of the deleted forms of the Bcd proteins them-
elves.
radients of Transcription Factors Produce Sharp
orders of Target Gene Expression
o determine whether the reduction of hb sharpening
bserved in the Bcd-DC and Bcd-DQC backgrounds
as due to the lack of specific sequences or to the
ack of transcriptional activities carried by the deleted
equences, we took advantage of transgenic flies ex-
ressing Gal4-derived transcription factors in Bcd-like
aternal gradients. These proteins activate transcrip-
ion and some of them bear no other structural or func-
ional similarities to Bcd [20]. Among them were Gal4-
Q, in which the Gal4 DNA binding domain is fused to
wo copies of the glutamine-rich (Q) domain of Bcd,
nd Gal4-3GCN4, in which the Gal4 DNA binding do-
ain is fused to three copies of the yeast GCN4 activa-
ion domain. We asked whether these gradients of
Precision and Sharpening of Bcd Activity
1891Figure 3. The Sharpness of the hb Posterior Border Is Reduced in the bcd-DC and bcd-DQC Mutants
(A) Domain structure of the 489 amino acid long Bcd protein: the histidine/proline-rich domain (HP; amino acids 11–42), the homeodomain
(HD; amino acids 91–152), the serine/threonine-rich activation domain (ST; amino acids 153–210), the glutamine-rich activation domain (Q;
amino acids 252–300), the alanine-rich repression domain (A; amino acids 301–342), and the C-terminal acidic activation domain (C; amino
acids 350–414) are indicated.
(B–D) Midstage embryos were hybridized with an antisense hb probe. Mothers were homozygous for bcdE1 (null allele) and carried two copies
of a transgene expressing the Bcd-C protein (B) or the Bcd-QC protein (C). Mothers were homozygous for bcdE3 (D). Bcd-C is deleted
from amino acids 344–489 and Bcd-QC is deleted from amino acids 247–304 and 344–489 [21]. The bcdE3 allele encodes a mutant protein
in which serine 126 is replaced by a leucine [6]. Diffuse borders of expression are indicated by brackets. Sharpening was measured (see
Figure S1 and Supplemental Experimental Procedures) on (n) midstage embryos and average measurements are indicated at the bottom.
Anterior is at the left.Gal4-derived transcription factors could also drive
sharp expression of their target genes. In early-stage
embryos, expression of the Gal4-reporters under con-
trol of the Gal4-2Q or the Gal4-3GCN4 transcription
factors appeared graded from the anterior pole of the
embryo (Figures 4A and 4B, brackets). Interestingly,
however, during the first half of cellularization, in mid-
stage embryos, the posterior borders of reporter gene’s
expression sharpened to 6% EL for Gal4-2Q (Figure 4C)
and to 6.7% EL for Gal4-3GCN4 (Figure 4D)—a similar
extent to the sharpening of hb, otd, and Bcd3-lacZ ex-
pression (Figure S2). Similar qualitative results were ob-
tained with fusion proteins bearing the other activation
domains of Bcd ([20], data not shown). These observa-
tions indicate that Bcd shares its ability to induce the
formation of a sharp border of expression with artificial
transcription factors that diffuse as maternal gradient
from the anterior pole of the embryo.
The Bcd-C and Bcd-QC proteins, which exhibit re-
duced hb’s sharpening ability, are able to drive expres-sion of hb and must contain at least one additional acti-
vation domain that is not sufficient for sharpening. This
is surprising since the known remaining activation do-
mains in these proteins are Q and ST (Figure 3A), which
are both able to drive sharp expression of the Gal4 re-
porters when fused to the Gal4 DNA binding domain
(Figure 4C, data not shown, [20]). The ability of the pro-
tein to drive sharpening is obviously influenced either
by the context of the Bcd protein in which the Q and
ST activation domains remains or by the number of ac-
tivation domains per se.
Bcd’s Ability to Activate Transcription Is Sufficient
for Precise Target Gene Expression
To understand how the Bcd target genes are expressed
in precisely sized domains, we quantified and com-
pared the position of the posterior border of hb, otd,
and Bcd3-lacZ expression in 30–50 midstage embryos
(Figure 5). In agreement with Houchmandzadeh et al.
[14], the position of the hb posterior border at midcellu-
Current Biology
1892Figure 4. Gal4-Derived Transcription Factors Expressed in a Bcd-like Gradient Drive Sharp Expression of Target Genes
Females carrying four copies of a transgene expressing, in a Bcd-like maternal gradient, the artificial transcription factor Gal4-2Q (A and C)
or Gal4-3GCN4 (B and D) were crossed with males carrying the transgene UASp-lacZ (A and C) or UASnls-lacZ (B and D). In situ hybridizations
with an antisense probe for lacZ were performed on early-stage embryos (A and B) and midstage embryos (C and D) from these crosses.
Diffuse borders of expression are indicated by brackets. Sharp borders of expression are indicated by arrow heads. Sharpening was measured
(see Figure S1 and Supplemental Experimental Procedures) on (n) midstage embryos and average measurements are indicated at the bottom
of (C) and (D).larization varied from 48%–52% EL [50.2% ± 1.5% EL,
Figure 5A]. In wild-type embryos, the locations of the
otd and Bcd3-lacZ posterior borders were, respec-
tively, at 72.1% ± 1.4% EL and 71.4% ± 1.6% EL (Fig-
ures 5B and 5C). These data indicate that, despite the
observed variability of the Bcd gradient, the posterior
borders of expression of these three Bcd direct targets
are very precisely positioned in wild-type embryos. The
promoter of Bcd3-lacZ does not contain binding sites
for other transcription factors and, since addition of Hb
binding sites drastically modifies its expression pattern
[18], it is highly unlikely that it contains cryptic binding
sites for Hb. The Bcd3-lacZ expression almost certainly
reflects the intrinsic activity of the Bcd protein [10, 22],
yet the Bcd gradient appears sufficient to induce its
very precise positioning. This observation indicates
that the mechanism allowing the precise positioning of
expression of Bcd target genes, despite the reported
variability of the Bcd gradient [17, 18], is a general fea-
ture of Bcd target genes. It can be driven solely by Bcd
binding sites and does not necessarily involve Bcd’s
partner, the Hb protein.
To determine if any particular sequences of the Bcd
protein were required for precision, we also quantified
the precision of UASp-lacZ expression from the Gal4-
3GCN4 and Gal4-2Q proteins: standard deviations were
1.7% of EL for Gal4-3GCN4 (Figure 5D) and 1.9% of EL
for Gal4-2Q (Figure 5E). These values are very similar
to the standard deviations obtained for the Bcd target
genes (compare Figures 5A–5E) and indicate that the
UASp-lacZ reporter gene was also expressed from the
Gal4-2Q or the Gal4-3GCN4 artificial maternal gradi-
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tnts in very precisely sized domains. Together, these
bservations demonstrate that precise target gene ex-
ression can be driven by DNA binding transcription
actors diffusing from the anterior pole of the embryo
s a gradient. As the Bcd and Gal4-3GCN4 proteins
ave no sequence homologies and only share an ability
o activate transcription, our experiments indicate that
his property is sufficient for precision and that any
ther components in the system that contribute to this
rocess must act upstream or at the level of transcrip-
ional activation.
he Precision of Bcd- and Gal4-Derived
ranscription Factors Is Reduced in StauHL
lthough the Bcd3-lacZ reporter is expressed more an-
eriorly than hb, one could argue that its precision is
ue to the steeper Bcd gradient in this region where
he requirements for accurate response might be less
emanding. Because the Stau protein was identified as
potential component contributing to the precision of
b expression, we asked whether the expression of
ore anterior Bcd target genes was affected in the
tauHL mutant background, a hypomorphic allele with
he strongest effect on hb precision [14]. In agreement
ith Houchmandzadeh et al. [14], in embryos from
tauHL females, the position of the hb posterior border
as much more variable than in wild-type embryos, as
hown by the distribution of the posterior border posi-
ions among 56 midstage embryos (Figure 6A), which
anged from 45%–66% EL (mean position 52% EL,
tandard deviation 4%). Interestingly, higher variability
han in wild-type embryos was also observed in em-
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1893Figure 5. Precise Positioning of the Posterior Borders of Expression of Bcd’s Target Genes during the First Half of Cellularization
In situ hybridizations with hb (A), otd (B) or lacZ (C–E) antisense probes were performed on embryos from wild-type females. Females carried
two (D) or four (E) copies of a transgene expressing, in a Bcd-like maternal gradient, the artificial transcription factors Gal4-3GCN4 (D) or
Gal4-2Q (E). Embryos carried the Bcd3-lacZ transgene (C) or the UASp-lacZ transgene (D and E). The distribution of the mean posterior
border positions among (n) midstage embryos is given for each target gene and/or genetic background. Average values and standard
deviations for the (n) embryos were calculated and are indicated at the bottom of each panel. Standard deviations observed were not
significantly different (p < 0.001).bryos from stauHL females for otd (Figure 6B), Bcd3-
lacZ (Figure 6C), and UASp-lacZ expressed from the
Gal4-3GCN4 artificial maternal gradient (Figure 6D).
Standard deviations were 2.5% for otd (Figure 6B),
2.4% for Bcd3-lacZ (Figure 6C), and 3.1% for UASp-
lacZ (Figure 6D). The standard deviations for these
three genes were of similar magnitude (Figures 6B–6D)
but were all clearly lower than the standard deviation
obtained for hb (compare in Figure 6A with Figures
6B–6D). This reduction is likely linked to the more ante-
rior position of the posterior borders of these three
Bcd target genes along the A-P axis. Since the
precision of otd, Bcd3-lacZ and UASp-lacZ expression
was significantly reduced in the stauHL mutant context
(p < 0.01; compare Figures 5B–5D with Figures 6B–6D),
we conclude that the Stau protein contributed not onlyto the precision of hb expression but, more generally,
to the precision of the Bcd morphogenic activity and to
the precision of an artificial Gal4-3GCN4 transcription
factor expressed as maternal gradient in the embryo.
The Involvement of Stau in the Precision
of Bcd Morphogenic Activity
Bcd and Gal4-3GCN4 have no specific sequence ho-
mologies, but they share an ability to activate transcrip-
tion and in our study, their mRNAs both contain the Bcd
3# untranslated sequence required for anchoring at the
anterior pole. Two processes may account for the con-
served effect of Stau on Bcd and Gal4-3GCN4 morpho-
genic activity: either Stau affects the activities of both
proteins and is directly involved in the general tran-
scription process, or the reduced precision of target
Current Biology
1894Figure 6. The Precision of Bcd’s Target Gene Expression and bcd mRNA Distribution Is Reduced in the stauHL Mutant Background
In situ hybridizations with hb (A), otd (B), lacZ (C and D), or bcd (E and F) antisense probes were performed on embryos from wild-type (E) or
stauHL (see [A]–[D] and [F]) females. Females carried two copies of a transgene expressing, in a Bcd-like maternal gradient, the artificial
transcription factors Gal4-3GCN4 (D). Embryos carried the Bcd3-lacZ transgene (C) or the UASp-lacZ transgene (D). The distribution of the
mean posterior border positions for (n) midstage embryos is given for each target gene and/or genetic background at the top of each panel.
Average values and standard deviations for the (n) embryos of were calculated and are indicated at the bottom of each panel.
(E and F) The distribution of XA (left edge of each light gray bar), XB (right edge of each light gray bar) and the mean position, M = [XA + XB]/2
(middle position of each light gray bar), is indicated at the top. Ranking was performed on increasing order of mean positions.genes expression in the stauHL background is related
to variation in anchoring of the Bcd and Gal4-3GCN4
encoding mRNAs at the anterior pole. We favored this
second hypothesis, because the original function of
Stau is precisely to regulate anchoring of the bcd
mRNA at the anterior pole through its 3# untranslated
region [16, 17]. To test it, we compared the anterior lo-
calization of the bcd mRNA in early-stage embryos
from wild-type and stauHL females. In wild-type em-
bryos the bcd mRNA is detected from the anterior pole
to a mean position of 84.3% EL (Figure 6E and Figures
S4A and S4B). In agreement with the previously iden-
tified role of Stau [16], the distribution domain of the
bcd mRNA is larger and expands toward the posterior
down to a mean position of 78.4% EL in embryos from
stauHL females (Figure 6F and Figures S4C and S4D).
Quantitative measurements indicate that the limit of the
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gcdmRNA detection domain is fuzzy with a sharpening
f 17% EL in wild-type (Figure 6E and Figures S4A and
4B) and 30% EL in stauHL background (Figure 6F and
igures S4C and S4D). The variability of bcd mRNA lo-
alization is indicated by a standard deviation of 1.2%
L (Figure 6E) in wild-type embryos, a value signifi-
antly different (p < 0.001) from the 3.2% EL standard
eviation observed in the stauHL background (Figure
F). These observations indicate that the bcd mRNA
istribution is more variable among embryos in the
tauHL background than in wild-type. Although Houch-
andzadeh et al. did not detect any variability in the
verage expression profiles of the Bcd protein in stauHL
ackground [14], the variability observed in bcd mRNA
istribution (Figure 6F and Figures S3C and S3D) may
ikely contribute to the variability of the Bcd morpho-
enic activity in this genetic context.
Precision and Sharpening of Bcd Activity
1895Discussion
In the present study, we show that Bcd binding sites
are sufficient in a promoter to allow its precise expres-
sion in an anterior domain with a sharp posterior border
in the Drosophila embryo. Sharpening and precision of
target gene’s expression was also obtained when Gal4-
derived transcription factors were allowed to diffuse in
Bcd-like maternal gradients, indicating that the ability
to activate transcription is sufficient for these pro-
cesses. These observations also indicate that, despite
the reportedly noisy nature of the Bcd-protein gradient
[17, 18], the “filter” allowing the precision of its activity
would have to be very general and not designed speci-
fically to the Bcd-hb network. To gain more insights into
the nature of this filter, we analyzed the expression of
the Bcd-reporter and the Gal4-reporter in stauHLmutant
background and observed that their precision was sig-
nificantly reduced. This observation indicated that the
effect of Stau in the precision of the Bcd-activity gradi-
ent occurs upstream or at the level of the activation
process. Because the Stau protein was originally in-
volved in the anchoring of the bcdmRNA at the anterior
pole, we compared the bcdmRNA distributions in wild-
type and stauHL mutant background. We observed that
it was more diffuse in the stauHL background with a
strong variability among embryos. We propose that
such variability accounts for the reduction of precision
observed for the Bcd and Gal4-dependent target
gene’s expression in this mutant background and that
the involvement of Stau in this process is consistent
with its well characterized activity in mRNA anchoring.
At last, because our data put into question the exis-
tence of a filtering system allowing the precision of the
Bcd-activity gradient despite the noisy nature of the
Bcd-protein gradient, we discuss the possibility that
the measurements of the Bicoid protein itself might be
the source of the noise.
The Smooth Morphogen Gradient Induces
Very Defined Domains of Expression
Expression of the direct target genes of Bcd appears
graded in the early embryo and, at first, reflects the
smooth gradient of the Bcd protein. Interestingly, it is
during the first half of cellularization that the posterior
borders of these expression domains resolve into sharp
focus, dividing the embryo into an anterior domain
where the target gene is on and a posterior domain
where the target gene is off. Our data indicate that Bcd
does not require other DNA binding transcription fac-
tors to induce this sharpening. Moreover, several tran-
scription factors artificially expressed in a Bcd-like
maternal gradient can also induce sharp expression of
their target genes in the blastoderm embryo. Because
activation domains of Bcd are required for the sharpen-
ing of hb, this process likely depends directly on the
transcription process per se.
We can propose several hypotheses to explain how
the sharpening of target gene expression during early
cellularization might take place. Firstly, it might involve
a repressor inhibiting Bcd’s activity possibly through
one of the repression domains identified in the Bcd pro-tein [20, 23]. This repressor would be expressed as a
gradient opposite to the Bcd gradient. Because sharp-
ening occurs with both the Bcd and Gal4-3GCN4 pro-
teins that have no sequence homologies, this repressor
must act very generally on the transcription process.
Another possibility could be that the response ele-
ments in Bcd target genes also contain binding sites
for repressors. A recent study argues that most of the
Bcd-dependent target elements contain Bcd binding
sites in combinations with Hb and/or Kr sites [24]. How-
ever, since sharpening is observed with the Bcd-
dependent and the Gal4-dependent reporters which
do not contain binding sites for other transcription fac-
tors, the repressor involved in sharpening in these
cases must not bind specifically to DNA. Secondly, co-
operative interactions between activation domains and
the transcriptional machinery might be involved [21].
Thirdly, chromatin modifications may be involved since
during this period of development dramatic changes
occur in the Drosophila embryo genome, which is at
first intensively replicating in the absence of zygotic
transcription and gradually becomes transcribed in the
absence of replication [25]. Finally, the process of cellu-
larization itself might play a role: it is possible that once
Bcd is confined within individual cells its activity has
a sharper threshold. However, since the cellularization
process is occurring normally in the embryos with re-
duced hb sharpening, it is clearly not sufficient.
The Variable Bcd Gradient Induces
Precise Expression
Our analysis of Bcd3-lacZ indicates that although it
contains only Bcd binding sites, its domain of expres-
sion is as precisely reproducible from one embryo to
another as those of hb and otd, the two other direct
Bcd target genes tested. Unexpectedly, the domain of
expression of Bcd3-lacZ does not mimic the wide vari-
ability in the Bcd-protein gradient described by Houch-
mandzadeh et al. [14] and Spirov et al. [15]. This vari-
ability of the Bcd-protein gradient was observed using
immunofluorescence microscopy of whole mount em-
bryos coupled to a quantitative detector of fluores-
cence. We also observed it frequently in immunochem-
istry experiments aiming to detect the Bcd-protein
gradient (N.D., unpublished data). Immunofluorescence
microscopy, like in situ hybridization, involves several
crucial steps, such as the permeabilization and fixation
of the embryo, that are subject to variation: we found
that embryos processed together frequently exhibited
a 2-fold variation in their staining level (data not shown).
Despite these variations, two parameters can be ana-
lyzed after the staining procedure: the intensity of the
staining and the frontiers that limit the domain of ex-
pression. Depending on the situation, these two param-
eters may be related or independent. In the case of hb
and the Bcd target genes, which are expressed in a
discrete domain with a clear-cut boundary, the domain
of expression itself (i.e., the position of the posterior
boundary) is not affected by variations in the intensity
of staining. In the case of the Bcd gradient, by contrast,
the domain of expression does not exhibit a clear cut
boundary but is rather limited by a large graded domain
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of staining.
We wondered how variations in the intensity of stain-
ing might affect detection of the Bcd-protein gradient
and detection of the expression domain of its main tar-
get protein Hb. To address this question, we performed
a simulation that mimics a 2-fold increase in the signal
detected either for Bcd (Figure 7A) or for Hb (Figure
7B). This simulation indicates that a 2-fold increase in
the Bcd signal induces a wide (around 20% EL) move-
ment of the gradient toward the posterior pole (Figure
7A). Interestingly, the same increase in the Hb signal
shifts the plateau (i.e., the level of expression) along the
y axis but induces only a 3% shift of the position of Hb
toward the posterior pole (Figure 7B). This simulation
indicates that even slight experimental variability in the
immunodetection protocol could affect the observed
position of the Bcd gradient much more than the posi-
tion of the posterior border of its target gene expres-
sion. In light of the precise expression of a simple Bcd
reporter gene, we propose that the Bcd-activity gradi-
ent is extremely precise and able, on its own, to drive
very accurate positional information along the A-P axis
of the embryo. The simulation illustrated in Figure 7
calls into question the degree of variability of the Bcd
protein gradient itself, which needs to be revisited
using experimental procedures that detect accurately a
less than 2-fold variability in Bcd concentration.
Systematic Variation Introduced by Dosage
and Temperature Have Little Effect on the Position
of the hb Expression Border
Two additional sets of experiments were provided by
Houchmandzadeh et al. to support the existence of a
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Expression of Bcd (A) and Hb (B) along the A-P axis are illustrated using arbitrary values for protein concentrations (y axis) as a function of
the percentage of EL. Numerical values were obtained from [14]. The anterior pole is at 100%. In each case, the gray curve is deduced from
the black curve by a simple 2X transformation. Arrows indicate the variation in the position of (A) the Bcd gradient and (B) the Hb posterior
border for an arbitrary detection threshold of 0.4.filtering system” transforming the noisy Bcd-protein
radient in a precise Bcd-activity gradient [14]. They
how that variation in temperature and in the gene dos-
ge of Bcd have much less effects than expected on
he position of Hb’s expression border. In the light of
ur results, we would like to revisit these experiments
nd discuss their interpretation. As expected [5, 7], in-
reases in the bcd gene dosage induced posterior
hifts of the Hb posterior border [14]. Quantitative mea-
urements indicated that these shifts decreased when
he gene dosage of Bcd increased and were, therefore,
maller than expected if they corresponded to propor-
ional increases in protein dosage and activity [14]. Al-
hough these observations could provide support for
he existence of a filtering system for Bcd activity [14],
hey could also be explained by alternative hypotheses.
irstly, it is possible that increases in the bcd gene dos-
ge do not allow corresponding quantitative increases
f the Bcd protein itself in the embryo. For instance,
he transgenes used might not express as much bcd
RNA as the endogenous gene (as frequently ob-
erved with transgenic insertions) and also, above a
ertain threshold of expression at the anterior pole, the
ranslation of the bcdmRNAmight be step limited. Sec-
ndly, the hb control region contains binding sites for
ranscription factors such as Hb itself. Importantly, the
osition of zygotic hb posterior border was shown to
e precisely shifted toward the anterior in the absence
f the Hb maternal protein (Hbmat) [21]. Because Hbmat
s restricted to the anterior half of the embryo by Nanos
26], it is difficult to determine how its absence in the
osterior half of the embryo might affect the extent of
he posterior shift of hb expression border in situations
here this border is precisely localized in the posterior
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dosage (four to six copies). The second approach pro-
vided by Houchmandzadeh et al. to support the exis-
tence of a filtering system for Bcd activity shows that
a reduction of temperature (from 29°C to 9°C) shifts the
Bcd-protein gradient toward the posterior but has little
effect on Hb expression [14]. An alternative hypothesis
is that such a decrease in temperature may directly af-
fect Bcd activity (for instance by reducing its DNA bind-
ing or transcriptional activity) and compensate its effect
on the position of the Bcd-protein gradient. At last, as
previously mentioned, the anterior restriction of Hbmat
might also be important to consider in this case, pre-
cisely because the expected shifts of Hb posterior bor-
der are localized in the region where the posterior bor-
der of Hbmat is localized.
Experimental Procedures
Drosophila Stocks and Transgenics
Mutant stocks were bcdE1, bcdE3 [26], and stauHL [16, 17] and were
obtained from the Bloomington stock Center. P element-trans-
formed lines were Bcd3-lacZ [10], Bcd-DC and Bcd-DQC [21],
UAS-placZ [27], Gal4-2Q, and Gal4-3GCN4 [20]. The Bcd-C and
Bcd-QC proteins were expressed under the control of the bcd
regulatory sequences [21]. The Gal4-2Q and Gal4-3GCN4 fusion
proteins were expressed in Bcd-like gradients under the control of
the maternal nanos promoter and the bcd 3# untranslated region
that allows the anchoring of their mRNAs at the anterior pole of the
embryo. The UAS-nlslacZ was constructed by Thomas Lecuit by
inserting five copies of an optimized Gal4 binding site upstream of
the hsp27 minimal promoter driving the expression of a nuclear
β-galactosidase in the pwnβ-E plasmid kindly provided by Ulrike
Gaul.
Whole-Mount In Situ Hybridization and Immunocytochemistry
Digoxigenin-labeled RNA probes and in situ hybridization were per-
formed as in [19] from pKS derivatives containing the coding se-
quences of the different genes studied. The anti-digoxigenin anti-
body coupled to alkaline phosphatase (Roche Diagnostics) was
preadsorbed and used at a 1/2000 dilution. Immunocytochemistry
was performed as described in [28] with the anti-Bcd antibody [6]
diluted to 1/500. Embryos were mounted in 80% glycerol and pho-
tographed by using Nomarski optics. The detailed procedures for
measurements of posterior border sharpening and position are de-
scribed in Figure S1 and in the Supplemental Experimental Pro-
cedures.
Supplemental Data
Supplemental Data include supplemental results, experimental
procedures, and four figures and are available at http://www.
current-biology.com/cgi/content/full/15/21/1888/DC1/.
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